Default Fellow

John Cohrssen

Filter By:

Topic

Recent Commentary

Analysis and Commentary

FDA Is The Wrong Agency To Regulate Genetically Engineered Animals

by John Cohrssen, Henry I. Millervia Nature
Wednesday, July 12, 2017

As individuals who spent years in US government positions (H.I.M. is a former special assistant to the US Food and Drug Administration (FDA) commissioner and founding director of the FDA's Office of Biotechnology; J.J.C. is former counsel to both the White House Biotechnology Working Group and the House Energy and Commerce Committee as well as former Senior Associate of the President's Advisory Council on Executive Organization), we know how important 'location, location, location' is for regulatory jurisdiction.

an image
Featured

To Modulate Drug Prices, We Need Less Regulation And More Competition

by Henry I. Miller, John Cohrssenvia National Review
Wednesday, January 25, 2017

Allowing drugs in the U.S. that have been approved abroad would greatly help patients, providers, and producers. 

Analysis and Commentary

The FDA’s Dr. Nos

by John Cohrssen, Henry I. Millervia Cato Institute
Thursday, January 5, 2017

The agency’s fear of Type II errors inhibits drug development and harms patients.

Featured

Drain The Regulatory Swamp, Let Agriculture Bloom

by John Cohrssen, Henry I. Millervia Forbes
Wednesday, December 7, 2016

Worries about slow economic growth have shifted the mood of America from “hope and change” eight years ago to “drain the swamp,” which is at least in part a realization that government regulation needs major fixes to spur innovation and job creation.

Analysis and Commentary

FDA's Demands And Delays Harm Desperate Patients

by Henry I. Miller, John Cohrssenvia Forbes
Wednesday, October 19, 2016

Regulators sometimes respond positively to public pressure. During the height of the AIDS epidemic of the 1980’s, for example, the Food and Drug Administration came under fire and its headquarters was literally stormed by AIDS activists protesting regulators’ unwillingness to make new investigational drugs available to patients who had no alternative treatment.

Analysis and Commentary

Why Are The Feds Blocking Technologies To Control The Mosquitoes That Spread Zika Virus?

by John Cohrssen, Henry I. Millervia Forbes
Wednesday, September 7, 2016

Zika virus infections, which in recent months have swept through South and Central America and the Caribbean, are typically mild and often go undetected, but infection can cause severe birth defects early in pregnancy and subtler ones later. It can also cause a progressive, usually temporary, paralysis called Guillain-Barré syndrome. 

Analysis and Commentary

Regulators’ Infectious Zika Incompetence

by Henry I. Miller, John Cohrssenvia National Review
Tuesday, August 2, 2016

Interdepartmental buck-passing, big-government sloth, and anti-science ideology are allowing a needless spread of the disease.

Analysis and Commentary

'GMO' Regulation: After 30 Years, Let Science Finally Show The Way

by Henry I. Miller, John Cohrssenvia Forbes
Wednesday, June 22, 2016

Regulations often evolve along with technology. When cars first were introduced in certain cities in the early 1900′s, policemen walked in front of them to ensure they didn’t injure anyone or anything. It soon became obvious that that precaution was both unnecessary and unworkable.

Analysis and Commentary

Deadly Dysfunction: Bureaucratic Snafus Delay A Novel Approach To Zika

by Henry I. Miller, John Cohrssenvia Forbes
Wednesday, May 4, 2016

Abandoning earlier caution about the relationship between the Zika virus and various serious possible sequelae, including microcephaly (a devastating condition in which babies are born with abnormally small heads and brains), CDC scientists have confirmed cause and effect.

Analysis and Commentary

The USDA's Meaningless Organic Label

by John Cohrssen, Henry I. Millervia Cato Institute
Monday, April 18, 2016

The courts could end this deceptive marketing program.

Pages